Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.266 EUR | +1.07% | -8.29% | -85.71% |
Chart calendar Pacific Biosciences of California, Inc.
Upcoming events on Pacific Biosciences of California, Inc.
Past events on Pacific Biosciences of California, Inc.
2024-03-12 10:15 am | Barclays Global Healthcare Conference |
2024-03-05 01:30 pm | TD Cowen Health Care Conference |
2024-02-15 05:00 pm | Q4 2023 Earnings Call |
2024-02-15 04:05 pm | Q4 2023 Earnings Release |
2024-01-10 04:30 pm | JPMorgan Healthcare Conference |
2023-11-28 03:00 pm | Piper Sandler Healthcare Conference |
2023-11-16 02:00 pm | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
2023-10-30 04:30 pm | Q3 2023 Earnings Call |
2023-10-30 04:03 pm | Q3 2023 Earnings Release |
2023-09-12 12:55 pm | Morgan Stanley Global Healthcare Conference |
2023-08-16 07:00 pm | UBS MedTech, Tools and Genomics Summit |
2023-08-02 05:00 pm | Q2 2023 Earnings Call |
2023-08-02 04:06 pm | Q2 2023 Earnings Release |
2023-06-13 11:00 am | Goldman Sachs Global Healthcare Conference |
2023-06-01 02:30 pm | Bernstein Strategic Decisions Conference |
2023-05-24 12:00 pm | Annual General Meeting |
2023-05-10 12:20 pm | Bank of America Healthcare Conference |
2023-05-06 | ABRF Annual Meeting |
2023-05-02 04:30 pm | Q1 2023 Earnings Call |
2023-05-02 04:01 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 90,9 88,4 2.84% | 78,9 76,5 3.07% | 131 130 0.02% | 128 128 0.06% | 201 201 -0.01% | 193 |
EBITDA Million USD | Released Forecast Spread | -93,3 -101 7.6% | -98,0 -95,4 -2.66% | -203 -187 -8.65% | -297 -291 -2.11% | -315 -300 -4.82% | -266 |
EBIT Million USD | Released Forecast Spread | -101 -108 6.65% | -104 -103 -1.66% | -210 -208 -1.06% | -307 -299 -2.75% | -334 -316 -5.98% | -286 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -84,1 -109 23.08% | 29,4 30,9 -4.89% | -275 -264 -4.03% | -314 -312 -0.82% | -318 -307 -3.52% | -279 |
Net income Million USD | Released Forecast Spread | -84,1 -109 23.08% | 29,4 30,7 -4.32% | -181 -177 -2.56% | -314 -312 -0.82% | -307 -298 -2.78% | -283 |
EPS USD | Released Forecast Spread | -0,55 -0,72 23.23% | 0,17 0,17 -1.92% | -0,89 -0,90 1.63% | -1,40 -1,39 -1% | -1,21 -1,18 -2.72% | -1,04 |
Announcement Date | 06/02/20 | 10/02/21 | 15/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 36,0 36,0 0.05% | 33,2 32,8 1.08% | 35,5 35,2 0.87% | 32,3 35,4 -8.73% | 27,4 27,3 0.24% | 38,9 34,4 13.15% | 47,6 39,9 19.19% | 55,7 48,6 14.51% | 58,4 58,3 0.08% | 42,6 | 45,9 | 50,1 | 56,6 | 59,6 |
EBITDA Million USD | Released Forecast Spread | -62,2 -57,3 -8.54% | -75,0 -63,5 -18.15% | -65,4 -71,5 8.51% | -72,0 -67,8 -6.34% | -84,3 -77,6 -8.68% | -88,3 -76,6 -15.29% | -71,1 -73,2 2.86% | -68,2 -74,7 8.72% | -77,7 -76,8 -1.16% | -73,4 | -69,3 | -65,5 | -62,7 | -63,0 |
EBIT Million USD | Released Forecast Spread | -64,7 -58,9 -9.73% | -77,5 -67,4 -15.05% | -68,0 -74,0 8.13% | -74,6 -70,3 -6.21% | -87,1 -79,0 -10.18% | -91,3 -80,0 -14.02% | -73,2 -78,0 6.19% | -73,0 -76,3 4.27% | -87,5 -78,2 -11.94% | -76,6 | -72,7 | -70,0 | -67,5 | -67,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,2 -62,4 -9.22% | -81,5 -71,1 -14.56% | -71,4 -77,8 8.26% | -77,0 -74,0 -4.07% | -84,4 -81,9 -3.07% | -88,0 -85,1 -3.38% | -69,8 -82,0 14.86% | -77,6 -101 23.46% | -82,7 -75,3 -9.89% | -76,4 | -72,5 | -69,0 | -66,2 | -66,3 |
Net income Million USD | Released Forecast Spread | -69,3 -62,4 -11.1% | -81,5 -71,1 -14.56% | -71,4 -77,8 8.26% | -77,0 -74,2 -3.79% | -84,4 -82,0 -2.87% | -88,0 -85,3 -3.13% | -69,8 -82,0 14.86% | -66,9 -101 34.02% | -82,0 -75,3 -8.94% | -76,4 | -72,5 | -69,0 | -66,2 | -66,3 |
EPS USD | Released Forecast Spread | -0,31 -0,28 -9.32% | -0,37 -0,32 -15.61% | -0,32 -0,34 5.4% | -0,34 -0,33 -2.51% | -0,37 -0,36 -2.45% | -0,36 -0,33 -8.6% | -0,28 -0,32 12.64% | -0,26 -0,35 24.72% | -0,31 -0,29 -7.83% | -0,28 | -0,26 | -0,25 | -0,24 | -0,24 |
Announcement Date | 15/02/22 | 04/05/22 | 03/08/22 | 07/11/22 | 16/02/23 | 02/05/23 | 02/08/23 | 30/10/23 | 15/02/24 | - | - | - | - | - |
2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 01:00 am | PHILIPS NV: Q1 2024 Earnings Release |
2024-04-29 06:00 am | REVVITY, INC.: Q1 2024 Earnings Release |
2024-04-30 06:20 am | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
2024-04-30 04:05 pm | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
2024-05-01 | BRUKER CORPORATION: Q1 2024 Earnings Release (Projected) |
2024-05-01 | INMODE LTD.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | HOLOGIC, INC.: Q2 2024 Earnings Release |
2024-05-02 04:05 pm | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
Past sector events for Pacific Biosciences of California, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PACB Stock
- P09 Stock
- Calendar Pacific Biosciences of California, Inc.